Robin LaChapelle

Insider Reports History

Location
Newtown Square, PA
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Robin LaChapelle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robin LaChapelle:

Company Role Class Num Shares Value Price $ Report Date Ownership
ArriVent BioPharma, Inc. Chief Operating Officer Common Stock 394,477 $8,587,093 $21.77 11 Jul 2025 Held by The MAKS Yao Trust
ArriVent BioPharma, Inc. Chief Operating Officer Common Stock 135,736 $309,478 $2.28 11 Jul 2025 Direct
ArriVent BioPharma, Inc. Chief Operating Officer Stock Option (right to buy) 130,000 02 Feb 2026 Direct

Insider Reports Filed by Robin LaChapelle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AVBP ArriVent BioPharma, Inc. 02 Feb 2026 1 $0 4 Chief Operating Officer 04 Feb 2026, 20:44
AVBP ArriVent BioPharma, Inc. 11 Jul 2025 6 +$25,429 4 Chief Operating Officer 15 Jul 2025, 07:00
AVBP ArriVent BioPharma, Inc. 03 Feb 2025 1 $0 4 Chief Operating Officer 14 Feb 2025, 16:25
AVBP ArriVent BioPharma, Inc. 19 Sep 2024 10 +$90,481 4 Chief Operating Officer 23 Sep 2024, 18:14
AVBP ArriVent Biopharma, Inc. 25 Jan 2024 0 $0 3 Chief Operating Officer 25 Jan 2024, 20:38